Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors DOI Open Access
Joshua J. Lingo, Ellen Voigt, Dawn E. Quelle

et al.

Oncotarget, Journal Year: 2024, Volume and Issue: 15(1), P. 638 - 643

Published: Sept. 30, 2024

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive, Ras-driven sarcomas characterized by loss of the

Language: Английский

NEK2 promotes the progression of osteosarcoma through the AKT/p-AKT pathway and interacts with FoxM1 DOI

Xin Tan,

X. H. Liang,

Yi Feng

et al.

Medical Oncology, Journal Year: 2025, Volume and Issue: 42(4)

Published: March 19, 2025

Language: Английский

Citations

0
Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma DOI Creative Commons
Jiatong Li,

Yang Bai,

He Zhang

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Sept. 11, 2024

Osteosarcoma is a common type of bone cancer characterized by poor prognosis due to its metastatic nature. The tumor microenvironment (TME) plays critical role in metastasis and therapy response. Therefore, our study aims explore the mechanism osteosarcoma, potentially opening new avenues for treatment.

Language: Английский

Citations

2
Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors DOI Open Access
Joshua J. Lingo, Ellen Voigt, Dawn E. Quelle

et al.

Oncotarget, Journal Year: 2024, Volume and Issue: 15(1), P. 638 - 643

Published: Sept. 30, 2024

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive, Ras-driven sarcomas characterized by loss of the

Language: Английский

Citations

0